David Bearden


Office: 503-494-0116

Robertson Life Sciences Building

OSU College of Pharmacy 2730 SW Moody Ave., CL5CP

OSU College of Pharmacy
2730 SW Moody Ave., CL5CP
Portland, OR 97201
Infectious Diseases Fellowship, University of Illinois at Chicago, 2000 Pharmacy Practice Residency, University of Utah Hospitals and Clinics, 1998 Pharm.D., University of Illinois at Chicago, 1997

Profile Field Tabs

Affiliated with: 
Pharmacy Professnl Instr
Portland - OHSU
Faculty Type: 
Pharmacy Practice
Research/Career Interests: 

David Bearden practices in the area of adult infectious diseases. His research interests include the pharmacokinetics of antimicrobials in special populations, the approach to drug therapy in patients infected with resistant pathogens and pharmacist involvement in vaccine preventable diseases.

Selected Publications

Bearden DT, Allen GP, Christensen JM.  Comparative in vitro activities of topical wound care products against community-associated methicillin-resistant Staphylococcus aureus.  J Antimicrob Chemother 2008;62:769-72.

McGregor JC, Allen GP, Bearden DT.  Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.  Ther Clin Risk Manag 2008;5:843-53.

Madaras-Kelly KJ, Remington RE, Oliphant CM, Sloan KL, Bearden DT.  Efficacy of oral b-lactam versus non-b-lactam treatment of uncomplicated cellulitis.  Am J Med 2008;121:419-25.

Touchette DR, Bearden DT, Ottum SA.  Research publication by pharmacist authors in major medical journals: Changes over a 10-year interval. Pharmacotherapy 2008;28:584–590.

Pai MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients.  Pharmacotherapy 2007;27:1081-91.

Garey KW, Pai MP, Suda KJ, Turpin RS, Rege MD, Mingo DE, Bearden DT.  Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf 2007;16:919-27.

Chen H, Suda KJ, Turpin RS, Pai MP, Bearden DT, Garey KW.  High vs. low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: A cost-effectiveness analysis. Curr Med Res Opin 2007;23:1057-65.

Garey KW, Turpin RS, Bearden DT, Pai MP, Suda KJ.  Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidemia. Int J Antimicrob Agents  2007;29:557-62.

Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.  Clin Infect Dis 2006;43:25-31.

Garey KW, Neuhauser MM, Bearden DT, Cannon JP, Lewis RE, Gentry LO, Kontoyiannis DP. Evaluation of antifungal usage in the surgical intensive care unit:  A multi-institutional study.  Mycoses 2006;49:226-31.

Bearden DT, Holt T. State-wide impact of pharmacist-delivered adult influenza vaccinations.  Am J Prev Med 2005;29:450-2.

Functional Group: